Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $46000.0.

  • International Stem Cell's Free Cash Flow fell 7909.09% to $46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$139000.0, marking a year-over-year decrease of 26746.99%. This contributed to the annual value of -$153000.0 for FY2024, which is 11802.12% down from last year.
  • Per International Stem Cell's latest filing, its Free Cash Flow stood at $46000.0 for Q3 2025, which was down 7909.09% from -$332000.0 recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Free Cash Flow peaked at $439000.0 during Q2 2023, and registered a low of -$394000.0 during Q1 2021.
  • In the last 5 years, International Stem Cell's Free Cash Flow had a median value of $46000.0 in 2025 and averaged -$18052.6.
  • In the last 5 years, International Stem Cell's Free Cash Flow crashed by 88108.11% in 2021 and then soared by 97391.3% in 2023.
  • International Stem Cell's Free Cash Flow (Quarter) stood at -$326000.0 in 2021, then skyrocketed by 124.23% to $79000.0 in 2022, then soared by 103.8% to $161000.0 in 2023, then plummeted by 146.58% to -$75000.0 in 2024, then soared by 161.33% to $46000.0 in 2025.
  • Its Free Cash Flow was $46000.0 in Q3 2025, compared to -$332000.0 in Q2 2025 and $222000.0 in Q1 2025.